NCT07119606View on ClinicalTrials.gov

Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)

NANot yet recruitingINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions

Genetic Disease

Interventions

DIAGNOSTIC_TEST

SHANK3 mutation

blood sampling for diagnostic test

Trial Locations (1)

75019

Robert Debré Hospital, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER